323 related articles for article (PubMed ID: 19517467)
1. Tumor border configuration added to TNM staging better stratifies stage II colorectal cancer patients into prognostic subgroups.
Zlobec I; Baker K; Minoo P; Hayashi S; Terracciano L; Lugli A
Cancer; 2009 Sep; 115(17):4021-9. PubMed ID: 19517467
[TBL] [Abstract][Full Text] [Related]
2. Role of desmoplasia in recurrence of stage II colorectal cancer within five years after surgery and therapeutic implication.
Crispino P; De Toma G; Ciardi A; Bella A; Rivera M; Cavallaro G; Polistena A; Fornari F; Unim H; Pica R; Cassieri C; Mingazzini PL; Paoluzi P
Cancer Invest; 2008 May; 26(4):419-25. PubMed ID: 18443963
[TBL] [Abstract][Full Text] [Related]
3. Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion.
Strzelczyk B; Szulc A; Rzepko R; Kitowska A; Skokowski J; Szutowicz A; Pawelczyk T
Ann Surg Oncol; 2009 May; 16(5):1287-94. PubMed ID: 19259744
[TBL] [Abstract][Full Text] [Related]
4. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of tumor-infiltrating lymphocytes for patients with colorectal cancer.
Huh JW; Lee JH; Kim HR
Arch Surg; 2012 Apr; 147(4):366-72. PubMed ID: 22508783
[TBL] [Abstract][Full Text] [Related]
7. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification.
Fassnacht M; Johanssen S; Quinkler M; Bucsky P; Willenberg HS; Beuschlein F; Terzolo M; Mueller HH; Hahner S; Allolio B; ;
Cancer; 2009 Jan; 115(2):243-50. PubMed ID: 19025987
[TBL] [Abstract][Full Text] [Related]
8. Circular tumor growth: a prognostic factor in stage II colorectal carcinoma.
Jimi S; Hotokezaka M; Eto TA; Hidaka H; Maehara N; Chijiiwa K
Hepatogastroenterology; 2008; 55(84):926-9. PubMed ID: 18705299
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of mesenteric tumor nodules in patients with stage III colorectal cancer.
Lo DS; Pollett A; Siu LL; Gallinger S; Burkes RL
Cancer; 2008 Jan; 112(1):50-4. PubMed ID: 18008365
[TBL] [Abstract][Full Text] [Related]
10. [Study on independent factors on the prognosis of colorectal carcinoma: TNM stage, tumor budding, perineural invasion, peritumoral-lymphocytic infiltration and urine glucose].
Xu FY; Dong JK; Zhu YM; Qu MJ; Wang FJ; Jin YS; Ren GP; Lai MD
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 May; 26(5):366-9. PubMed ID: 16053766
[TBL] [Abstract][Full Text] [Related]
11. Improvement of staging by combining tumor and treatment parameters: the value for prognostication in rectal cancer.
Gosens MJ; van Krieken JH; Marijnen CA; Meershoek-Klein Kranenbarg E; Putter H; Rutten HJ; Bujko K; van de Velde CJ; Nagtegaal ID;
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):997-1003. PubMed ID: 17544876
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of CD8+ T cell and macrophage peritumoral infiltration in colorectal cancer.
Funada Y; Noguchi T; Kikuchi R; Takeno S; Uchida Y; Gabbert HE
Oncol Rep; 2003; 10(2):309-13. PubMed ID: 12579264
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
Lugli A; Vlajnic T; Giger O; Karamitopoulou E; Patsouris ES; Peros G; Terracciano LM; Zlobec I
Hum Pathol; 2011 Dec; 42(12):1833-40. PubMed ID: 21664647
[TBL] [Abstract][Full Text] [Related]
14. DNA image cytometry predicts disease outcome in stage II colorectal carcinoma.
Buhmeida A; Hilska M; Elzagheid A; Laato M; Collan Y; Syrjänen K; Pyrhönen S
Anticancer Res; 2009 Jan; 29(1):99-106. PubMed ID: 19331138
[TBL] [Abstract][Full Text] [Related]
15. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors of colorectal carcinoma in the elderly after radical surgery].
Liang JW; Bai XF; Zhou ZX; Zhao DB; Wang CF; Zhao P
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1467-70. PubMed ID: 18953852
[TBL] [Abstract][Full Text] [Related]
17. Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more.
Nagayoshi K; Ueki T; Nishioka Y; Manabe T; Mizuuchi Y; Hirahashi M; Oda Y; Tanaka M
Dis Colon Rectum; 2014 Apr; 57(4):467-74. PubMed ID: 24608303
[TBL] [Abstract][Full Text] [Related]
18. The impact of T and N stage on long-term survival of rectal cancer patients in the community.
Kozak KR; Moody JS
J Surg Oncol; 2008 Sep; 98(3):161-6. PubMed ID: 18615481
[TBL] [Abstract][Full Text] [Related]
19. Long-term prognostic value of detection of circulating colorectal cancer cells using CGM2 reverse transcriptase-polymerase chain reaction assay.
Douard R; Wind P; Sales JP; Landi B; Berger A; Benichou J; Gayral F; Loric S; Cugnenc PH
Surgery; 2006 Apr; 139(4):556-62. PubMed ID: 16627067
[TBL] [Abstract][Full Text] [Related]
20. The depth of tumor invasion beyond the outer border of the muscularis propria as a prognostic factor for T3 rectal/rectosigmoid cancer.
Yoshida K; Yoshimatsu K; Otani T; Yokomizo H; Ogawa K
Anticancer Res; 2008; 28(3B):1773-8. PubMed ID: 18630458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]